Table I.
Patient Characteristics at Diagnosis
| No. | Percentage | |
|---|---|---|
| Age (yrs) (Median 69, Range 34–97) | ||
| <50 | 20 | 10.3% |
| 50–70 | 92 | 47.1% |
| >70 | 83 | 42.6% |
| Sex | ||
| Male | 114 | 58.5% |
| Female | 81 | 41.5% |
| Race | ||
| White | 191 | 97.9% |
| Black | 1 | 0.5% |
| Asian | 3 | 1.5% |
| Immunosuppression (n=193) | ||
| HIV | 3 | 1.6% |
| Solid organ transplant | 4 | 2.1% |
| Chronic lymphocytic leukemia | 8 | 4.1% |
| TOTAL | 15 | 7.8%‡ |
| Extent of Disease (n=187) | ||
| Local only (< 2cm diameter) | 68 | 36.4% |
| Local only (≥ 2cm diameter) | 38 | 20.3% |
| Nodal | 70 | 37.4%T |
| Distant Metastatic | 11 | 5.9% |
| Interval from Appearance to Biopsy (n=144) | ||
| Median: 3 months | ||
| Mean: 5.3 months | ||
| Range: 1–54 months | ||
N=195 except when otherwise noted.
‡
16-fold over-representation of immunosuppression as compared to the general US population based on estimated prevalences of: chronic lymphocytic leukemia 0.029%, HIV 0.4% and living solid organ transplant recipients with viable grafts 0.075%
T
Nodal disease assessed by palpation or histologic evaluation (when performed).